| Literature DB >> 27579699 |
Pierre Andonian1, Magalie Viallon1,2, Caroline Le Goff3, Charles de Bourguignon1, Charline Tourel4, Jérome Morel4, Guido Giardini5, Laurent Gergelé4, Grégoire P Millet6, Pierre Croisille1,2.
Abstract
In sports medicine, there is increasing interest in quantifying the elastic properties of skeletal muscle, especially during extreme muscular stimulation, to improve our understanding of the impact of alterations in skeletal muscle stiffness on resulting pain or injuries, as well as the mechanisms underlying the relationships between these parameters. Our main objective was to determine whether real-time shear-wave elastography (SWE) can monitor changes in quadriceps muscle elasticity during an extreme mountain ultra-marathon, a powerful mechanical stress model. Our study involved 50 volunteers participating in an extreme mountain marathon (distance: 330 km, elevation: +24,000 m). Quantitative SWE velocity and shear modulus measurements were performed in most superficial quadriceps muscle heads at the following 4 time points: before the race, halfway through the race, upon finishing the race and after recovery (+48 h). Blood biomarker levels were also measured. A significant decrease in the quadriceps shear modulus was observed upon finishing the race (3.31±0.61 kPa) (p<0.001) compared to baseline (3.56±0.63 kPa), followed by a partial recovery +48 h after the race (3.45±0.6 kPa) (p = 0.002) across all muscle heads, as well as for each of the following three muscle heads: the rectus femoris (p = 0.003), the vastus medialis (p = 0.033) and the vastus lateralis (p = 0.001). Our study is the first to assess changes in muscle stiffness during prolonged extreme physical endurance exercises based on shear modulus measurements using non-invasive SWE. We concluded that decreases in stiffness, which may have resulted from quadriceps overuse in the setting of supra-physiological stress caused by the extreme distance and unique elevation of the race, may have been responsible for the development of inflammation and muscle swelling. SWE may hence represent a promising tool for monitoring physiologic or pathological variations in muscle stiffness and may be useful for diagnosing and monitoring muscle changes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27579699 PMCID: PMC5007013 DOI: 10.1371/journal.pone.0161855
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1a) US image obtained in axial plane showing the different areas of interest within the quadriceps muscle: the RF, rectus femoris (red); the VL, vastus lateralis (pink); and the VM, vastus medialis (green). b) Elastographic data collection: 5 circular 5 mm-diameter ROIs (Q boxes) were manually placed within each squared SWE box by the same radiologist, who was experienced in performing musculoskeletal ultrasound. For example, this picture shows the positions of the Q boxes for the RF. The operator was blinded to the quantitative shear modulus data. c), d), E) and f) are in-plane fiber-aligned US images of the RF, VM, VL, respectively. The orange-dotted square ROIs correspond to the three sequential positions of the SWE-boxes used for the SWE measurements. Thus, at each investigation time, 9 SWE boxes were saved (3 for the RF, 3 for the VM and 3 for the VL). Note the absence of gas bubbles within the thick gel layer. The X- and Y-scales are, respectively, the in-plane and depth distances in centimeters.
Demographic and training profile data.
| Pre | Mid | Finish | Recovery | |
|---|---|---|---|---|
| N | 50 | 31 | 27 | 27 |
| Sex (male/female) | 46/4 | 31/1 | 30/1 | 29/0 |
| Age (years) | 43 ± 9.1 | 43 ± 8.6 | 43 ± 8.7 | 43 ± 8.6 |
| Height (meters) | 1.75 ± 6.2 | 1.75 ± 6.4 | 1.75 ± 6.3 | 1.75 ± 5.6 |
| Weight (kg) | 72.2 ± 8 | 71.7 ± 8.2 | 70.7 ± 7.2 | 70.8 ± 7.3 |
| BMI (kg.m-2) | 23.6 ± 2.0 | 23.4 ± 2.0 | 23.1 ± 2.1 | 23.1 ± 2.0 |
| Body temperature (°C) | 36.2 ± 0.9 | 37.3 ± 0.5 | 37.3 ± 0.5 | 37.1 ± 0.7 |
| Pain | 0.00 ± 0 | 4.1 ± 2.9 | 3.6 ± 2.9 | 1.08 ± 1.7 |
| Training/week (n) | 3.94 ± 1.7 | 3.94 ± 1.5 | 3.94 ±1.5 | 3.94 ± 1.5 |
| Running experience (years) | 14.2 ± 10.4 | 13.5 ± 10.5 | 13.3 ± 10.6 | 13.1 ± 9.8 |
| Experience in ultra-marathons (years) | 5.3 ± 3.6 | 5.5 ± 3.6 | 5.6 ± 3.6 | 5.3 ± 3.6 |
| Previous ultra-marathons (n) | 13 ± 10 | 11 ± 9 | 11 ± 9 | 11 ± 9 |
| Limb dominance (R/L) | 43/7 | 27/4 | 23/4 | 23/4 |
All values are presented as the mean (standard deviation)
Thigh pain was quantified on a visual analog scale
Body mass index (BMI) was calculated as weight/height squared (kg·m-2)
Pre, Mid, Finish and Recovery were the four key measurement time points:
Pre (pre-race) measurements were performed within 4 days before the race
Mid (mid-race) measurements were performed at the mid-point of the race (148.7 km, D+9270 m)
Finish measurements were performed at the end of the race, within 1 h after finishing
Recovery measurements were performed after 48–72 h of recovery
Relative (intraclass coefficient) and absolute (standard error of measurement) shear modulus (μ) reliability.
| Time | Muscle | ICC (95% CI) | SEM (kPa) |
|---|---|---|---|
| RF | 0.89 (0.84–0.93) | 0.16 | |
| 1(Pre) | VM | 0.9 (0.89–0.96) | 0.12 |
| VL | 0.83 (0.75–0.89) | 0.19 | |
| global | 0.90 (0.86–0.94) | 0.20 | |
| RF | 0.92 (0.88–0.96) | 0.15 | |
| 2(Mid) | VM | 0.86 (0.78–0.92) | 0.18 |
| VL | 0.87 (0.79–0.93) | 0.19 | |
| global | 0.88 (0.82–0.94) | 0.18 | |
| RF | 0.92 (0.87–0.95) | 0.15 | |
| 3(Arrival) | VM | 0.85 (0.75–0.91) | 0.16 |
| VL | 0.93 (0.89–0.96) | 0.13 | |
| global | 0.93 (0.89–0.96) | 0.17 | |
| RF | 0.91 (0.85–0.95) | 0.14 | |
| 4(Recovery) | VM | 0.93 (0.88–0.96) | 0.14 |
| VL | 0.92 (0.87–0.95) | 0.14 | |
| global | 0.92 (0.87–0.96) | 0.14 |
RF, rectus femoris; VM, vastus medialis; VL, vastus lateralis; CI, confidence interval; SEM, standard error of measurement used as an indicator of absolute reliability
Longitudinal shear modulus (μ) and shear wave velocity (Vs) variations over time.
| Muscle | Pre | Mid | Finish | Recovery | |
|---|---|---|---|---|---|
| Rectus femoris | 3.84 (0.49) | 4.04 (0.71) | 3.56 (0.57) | 3.8 (0.47) | |
| 1.96 (0.13) | 2.00 (0.18) | 1.88 (0.16) | 1.95 (0.12) | ||
| Vastus medialis | 2.97 (0.48) | 2.96 (0.49) | 2.81 (0.45) | 2.95 (0.48) | |
| 1.72 (0.14) | 1.72 (0.14) | 1.67 (0.14) | 1.71 (0.14) | ||
| Vastus lateralis | 3.85 (0.47) | 3.87 (0.53) | 3.56 (0.48) | 3.48 (0.5) | |
| 1.96 (0.12) | 1.96 (0.13) | 1.89 (0.13) | 1.89 (0.13) | ||
Values are presented as the mean (SD) of the shear modulus (μ) and shear wave velocity (Vs)
Pre, Mid, Finish and Recovery correspond to each measurement time
Longitudinal variations in blood biomarkers throughout the ultra-marathon race.
| Pre | Mid | Finish | Recovery | |
|---|---|---|---|---|
| 133.29 (71.80) | 4123.30 (3846.10) | 733.52 (626.31) | ||
| 27.84 (8.55) | 547.28 (436.49) | 86.78 (44.32) | ||
| 166.04 (29.87) | 507.56 (255.70) | 428.23 (177.49) | ||
| 1.83 (0.40) | 1.74 (0.52) | 2.02 (0.54) | ||
| 1.17 (1.78) | 16.65 (15.0) | 5.87 (4.71) | ||
| 36.11 (7.95) | 56.09 (15.80) | 39.18 (9.38) | ||
| 0.97 (0.11) | 1.13 (0.16) | 0.95 (0.10) | ||
| 93.53 (11.67) | 86.67 (16.21) | 91.85 (13.91) | ||
| 140.62 (1.80) | 155.92 (6.34) | 151.76 (10.19) | ||
| 4.06 (0.39) | 4.06 (0.42) | 3.98 (0.36) | 4.24 (0.51) | |
| 72.63 (3.56) | 74.57 (4.61) | 71.86 (5.42) | ||
| 285.27 (3.68) | 286.40 (6.35) | 287.42 (4.86) | ||
| 43.53 (2.47) | 37.92 (3.02) | 40.54 (2.84) | ||
| 7.02 (1.55) | 8.51 (1.76) | 6.32 (1.46) | ||
| 4.17 (1.14) | 5.93 (1.57) | 4.10 (1.24) |
LDH, Lactate dehydrogenase
Glomerular filtration rate (GFR) was calculated according to the CKD-Epi formula
Bold values are peak changes over time
Values are shown as the mean (SD)
* p<0.05
** p<0.001 for post hoc paired comparisons with Pre values
Percent changes in biomarker levels and shear modulus values between the Finish and Pre sessions (% change Finish/Pre).
| % change Finish/Pre | r | p | |
|---|---|---|---|
| Creatine kinase (UI.L-1) | 2697.7 (348.5 | 0.07 | 0.49 |
| Myoglobin (μg.L-1) | 2024.7 (168.1 | -0.01 | 0.89 |
| LDH (UI.L-1) | 280.5 (16.4 | 0.08 | 0.46 |
| Lactate (mmol.L-1) | 21.2 (4.3 | -0.12 | 0.28 |
| C-reactive protein (mg.L-1) | 2443.8 (226.1 | -0.18 | 0.09 |
| Serum uric acid (mg.dL-1) | 63.1 (4.2 | -0.09 | 0.41 |
| Serum creatinine (mg.dL-1) | 16.3 (2.5 | -0.26 | 0.01 |
| GFR (mg.L-1) | -0.26 (1.2 | 0.27 | 0.01 |
| Sodium (mmol.L-1) | 14.1 (0.6 | -0.12 | 0.26 |
| Potassium (mmol.L-1) | -0.8 (1.1 | 0.10 | 0.33 |
| Serum total protein (g.L-1) | 2.7 (0.5 | -0.07 | 0.49 |
| Plasma osmolality (mosm.L-1) | 0.4 (0.2 | -0.23 | 0.02 |
| Hematocrit (%) | -12.4 (0.4 | 0.06 | 0.57 |
| White blood cells (x10³.μL-1) | 23.6 (2.8 | -0.28 | 0.01 |
| Neutrophils (x10³.μL-1) | 51.8 (4.7 | -0.26 | 0.01 |
LDH, Lactate dehydrogenase
Glomerular filtration rate (GFR) was calculated according to the CKD-Epi formula
Values are shown as the mean (SD)
P was calculated via post hoc paired comparisons between the Finish and Pre sessions